Autoimmunity Reviews

Article	Citations
Aquaporins: Unexpected actors in autoimmune diseases	386
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	254
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	193
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	185
Editorial Board	175
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	149
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	140
Current landscape of monogenic autoinflammatory actinopathies: A literature review	123
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	119
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	119
Editorial Board	108
Vitamin D deficiency and non-infectious uveitis: A systematic review and Meta-analysis	105
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	96
Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies	81
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	81
Comprehensive reproductive healthcare for women with immune-mediated inflammatory diseases: Addressing rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease through life's stages	74
Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review	73
Editorial Board	71
Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review	68
Inflammatory muscle involvement in systemic vasculitis: A systematic review	64
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	61
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis	54
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	54
“Fibromyalgia syndrome” related to Essure devices	54
Gut-tropic T cells and extra-intestinal autoimmune diseases	53

Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review	52
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	50
B lymphocytes, the gastrointestinal tract and autoimmunity	49
The biology of symptom-based disorders – time to act	48
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	48
Persistent aortic inflammation in patients with giant cell arteritis	48
Editorial Board	48
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review	48
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge	48
Molecular mimicry between SARS-CoV-2 and human proteins	44
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	44
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system	43
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?	42
Editorial Board	41
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	40
Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine	39
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response	39
From inflammation to renal fibrosis: A one-way road in autoimmunity?	37
Editorial Board	37
Sjögren's Syndrome: an undiagnosed etiology for facial pain Case series with review of neurological manifestation of Sjögren syndrome	37
Non-pharmacological interventions in the treatment of rheumatoid arthritis: A systematic review and meta-analysis	36
Undifferentiated connective tissue disease at risk for systemic sclerosis: Development of a short-term predictive score and a risk stratification tool	36
JAK inhibitors and systemic sclerosis: A systematic review of the literature	35
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	35
Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward	35
Key points to consider for an improved detection and characterization of cryoglobulins	34
When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?	34
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	33
Emerging role of galectin family in inflammatory autoimmune diseases	33
Should we use nintedanib as early therapy in patients with SSc-ILD?	33
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	33
Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers	33
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis	32
Ocular involvement in monogenic autoinflammatory disease	32
Caffeine and rheumatoid arthritis: A complicated relationship	31
Successful treatment of IgG4-related disease with tocilizumab monotherapy	31
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	31
Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome	30
The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger	30
Serum calprotectin is a marker of disease activity in Giant cell arteritis	30
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)	30
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	29
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	29
Is it time for treat-to-target in antiphospholipid syndrome?	29
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis	29
Susac syndrome: A scoping review	29
The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19	28
Salivary gland involvement in ANCA-associated vasculitis	28
Pemphigoid of the pulmonary system (POPS): A review of a less recognized feature	28
Renal involvement in systemic sclerosis	27

A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	27
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	27
Antiphospholipid antibodies and COVID-19	27
Circulating Calprotectin (cCLP) in autoimmune diseases	27
Histopathological prognostic factors in ANCA-associated glomerulonephritis.	27
Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms	26
Transverse myelitis in systemic lupus erythematosus: A case report and systematic literature review	26
Characteristics and prognosis of IgG4-related skin disease: A case report and systematic literature review	26
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	26
Tyrosine kinase 2 inhibitors in autoimmune diseases	26
Low-dose interleukin-2: A potential treatment for pemphigus vulgaris	25
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders	25
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis	25
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping review	24
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	24
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	24
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	23
Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-C	23
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	23
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	23
A comprehensive review of the advances in neuromyelitis optica spectrum disorder	23
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities	23
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	22
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies	22
Targeted delivery in scleroderma fibrosis	22
Antiphospholipid syndrome in the era of COVID-19 – Two sides of a coin	22
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	21
Nutrition and its role in prevention and management of rheumatoid arthritis	21
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	20
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	20
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	20
Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection	20
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases	20
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	19
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	19
The role of innate immunity in myasthenia gravis	19
Immunopathogenesis of systemic lupus erythematosus: An update	19
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	19
Significance of IL-7 and IL-7R in RA and autoimmunity	19
Editorial Board	19
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review	18
Autoimmune pre-disease	18
Cardiovascular and cerebrovascular outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: A systematic review with meta-analysis	18
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	18
Recommendations for randomised controlled trials on fibromyalgia and myalgic encephalomyelitis	18
Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence	18
Editorial Board	18
ASIA (Shoenfeld's syndrome) due to hysteroscopic Essure sterilization	17
Editorial Board	17
Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19”	17
Editorial Board	16
Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis	16
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers	16
Editorial Board	16
Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era	16
Editorial Board	16
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	16
Editorial Board	16
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic	16
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	16
Editorial Board	16
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	16
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases	15
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	15
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	15
Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review	15
Tumour- associated autoantibodies as prognostic cancer biomarkers- a review	15
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	15
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	15
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications	15
Don't mix apples and oranges. Reply to Azoulay et al.	15
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma	15
Infectious side effects of baricitinib: A big data analysis based on VigiBase	15
The impact of menopause on multiple sclerosis	15
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	15
Functional autoantibodies: Definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders	15
Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies	15
Basophils in autoimmunity: Systemic lupus erythematosus and more?	14
Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?	14
Editorial Board	14

Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	14
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	14
Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis	14
Posterior reversible encephalopathy syndrome and autoimmunity	14
Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease	14
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	14
Editorial Board	14
Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis	14
Autoimmune pancreatitis - What we know and what do we have to know?	13
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	13
The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis	13
Cranial giant cell arteritis mimickers: A masquerade to unveil	13
Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease	13
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent	13
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	13
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	13
Relapsing polychondritis - A single Centre study in the United Kingdom	13
Seronegative autoimmune diseases: A challenging diagnosis	13
Rheumatoid arthritis: Extra-articular manifestations and comorbidities	13
Psychiatric manifestations of autoimmune encephalitis	13
Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis	13
Autoimmunity and COVID-19 – The microbiotal connection	12
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	12
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms	12
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction	12
Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases	12
To be, or not to be… Guillain-Barré Syndrome	12
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	12
Heart rate variability (HRV): Checklist for observational and experimental studies	12
Childhood mixed connective tissue disease at disease onset: Evidence from a systematic review	12
Novel tracers for molecular imaging of interstitial lung disease: A state of the art review	12
Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review	12
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	12
Nonsystemic vasculitic neuropathy: Presentation and long-term outcome from a French cohort of 50 patients	11
Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy	11
Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus	11
Mesenchymal stromal cells for systemic sclerosis treatment	11
The role of B cell metabolism in autoimmune diseases	11
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review	11
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?	11
Autoimmunity in vitiligo: Therapeutic implications and opportunities	11
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	11
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	11
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study	10
Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis	10
Intermittent fasting: A promising dietary intervention for autoimmune diseases	10
Anorexia nervosa, immunity and autoimmunity	10
Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases	10
An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions	10
Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases	10
The current state of knowledge of the immune ecosystem in alopecia areata	10
MicroRNAs in pemphigus and pemphigoid diseases	10
Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool?	10
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop	10
Friend or foe: RIG- I like receptors and diseases	10
Blood-dominant disease in late-and-early-onset lupus: A systematic review and meta-analysis	10
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets	10
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	10
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	10
Corrigendum to “Anti-rods/rings autoantibody and IMPDH filaments: An update after fifteen years of discovery” [AUTREV 19–10 (2020) 102643]	10
Antibody glycosylation in autoimmune diseases	10
The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications	9
Neuroimmune communication of the cholinergic system in gut inflammation and autoimmunity	9
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	9
Pathogenesis-based new perspectives of management of ANCA-associated vasculitis	9
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases	9
Can anticoagulation be withdrawn in APS patients after aPL negativization?	9
Field synopsis and systematic meta-analyses of genetic association studies in neuromyelitis optica	9
Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis	9
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	9
The autoimmune aetiology of unexplained chronic pain	9
Neuropsychiatric involvement in systemic lupus erythematosus: A review	9
Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis	9
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	9
New insights for regulatory T cell in lupus nephritis	9
Global analysis of antiphospholipid syndrome and stroke research: identifying emerging trends, international collaborations, and knowledge gaps	9
Bone health in idiopathic inflammatory myopathies	9
Engineered antigen-specific regulatory T cells for autoimmune skin conditions	9
Editorial Board	9
The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis	9
SpA plus IBD or IBD plus SpA: Does commutative property apply?	8
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	8
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	8
Ethnicity also influences the clinical heterogeneity of mixed connective tissue disease of childhood onset: The French West Indies experience	8
Editorial Board	8
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	8
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	8
Systematic review of anti-dsDNA testing for systemic lupus erythematosus: A meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay	8
Editorial Board	8
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study	8
Scleroderma specific autoantibodies and MS-like manifestations: A novel association?	8
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review	8
Histopathological features of systemic sclerosis-associated myopathy: A scoping review	8
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	8
Letter to the editor: Prevalence of connective tissue disease autoantibodies in a large longitudinal population-based cohort from the Netherlands	8